Literature DB >> 31542854

Congenital fibrinogen disorders with repeated thrombosis.

Xiuli Zhang1, Chuang Zhang1, Baoheng Wang1, Ningheng Chen1, Gaihe Sun1, Xueli Guo2.   

Abstract

Congenital dysfibrinogenemia is characterized with undetectable or low fibrinogen level by Clauss assay complicated by bleeding and/or thrombosis. These may lead to a diagnostic problem to some clinicians unfamiliar with this disease. We reported a case of congenital dysfibrinogenemia manifested as hemorrhage, repeated thrombosis, low fibrinogen levels through Clauss assay and but normal levels of fibrinogen through PT-derived tests. In conclusion, to patients with thrombosis complicated by decreased fibrinogen level, clinicians and laboratory physicians should be alert to the possibility of congenital dysfibrinogenemia.

Entities:  

Keywords:  Congenital dysfibrinogenemia; Congenital fibrinogen disorders; Fibrinogen; Thrombosis

Year:  2020        PMID: 31542854     DOI: 10.1007/s11239-019-01958-y

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  19 in total

1.  Fibrinogen Otsu I:A gammaAsn319,Asp320 deletion dysfibrinogen identified in an asymptomatic pregnant woman.

Authors:  Fumiko Terasawa; Kelly A Hogan; Satomi Kani; Masaya Hirose; Yutaka Eguchi; Yoichi Noda; Minoru Hongo; Nobuo Okumura
Journal:  Thromb Haemost       Date:  2003-10       Impact factor: 5.249

2.  Congenital hypodysfibrinogenaemia (Fibrinogen Des Moines) due to a gamma320Asp deletion at the Ca2+ binding site.

Authors:  Stephen O Brennan; Ryan L Davis; Michael W Mosesson; Irene Hernandez; Robin Lowen; Saramma J Alexander
Journal:  Thromb Haemost       Date:  2007-08       Impact factor: 5.249

Review 3.  Fibrinolysis and the control of blood coagulation.

Authors:  John C Chapin; Katherine A Hajjar
Journal:  Blood Rev       Date:  2014-09-16       Impact factor: 8.250

Review 4.  Congenital fibrinogen disorders: an update.

Authors:  Philippe de Moerloose; Alessandro Casini; Marguerite Neerman-Arbez
Journal:  Semin Thromb Hemost       Date:  2013-07-12       Impact factor: 4.180

5.  Natural history of patients with congenital dysfibrinogenemia.

Authors:  Alessandro Casini; Marc Blondon; Aurélien Lebreton; Jérémie Koegel; Véronique Tintillier; Emmanuel de Maistre; Philippe Gautier; Christine Biron; Marguerite Neerman-Arbez; Philippe de Moerloose
Journal:  Blood       Date:  2014-10-15       Impact factor: 22.113

Review 6.  Severe Thrombotic Complications in Congenital Afibrinogenemia: A Pathophysiological and Management Dilemma.

Authors:  Cristina Santoro; Fulvio Massaro; Salvatore Venosi; Saveria Capria; Erminia Baldacci; Roberto Foà; Maria Gabriella Mazzucconi
Journal:  Semin Thromb Hemost       Date:  2016-06-02       Impact factor: 4.180

7.  Hypodysfibrinogenaemia and thrombosis in association with a new fibrinogen γ chain with two mutations (γ114Tyr→His, and γ320Asp deleted).

Authors:  Stephen O Brennan; Meera Chitlur
Journal:  Thromb Haemost       Date:  2013-03-07       Impact factor: 5.249

8.  Two novel mutations in the fibrinogen γ nodule.

Authors:  Roman Kotlín; Ondřej Pastva; Jana Stikarová; Alžběta Hlaváčková; Jiří Suttnar; Leona Chrastinová; Tomáš Riedel; Peter Salaj; Jan E Dyr
Journal:  Thromb Res       Date:  2014-07-21       Impact factor: 3.944

9.  Screening of dysfibrinogenaemia using the fibrinogen function versus antigen concentration ratio.

Authors:  B Krammer; O Anders; H R Nagel; C Burstein; M Steiner
Journal:  Thromb Res       Date:  1994-12-15       Impact factor: 3.944

Review 10.  Dysfibrinogenemia: from molecular anomalies to clinical manifestations and management.

Authors:  A Casini; M Neerman-Arbez; R A Ariëns; P de Moerloose
Journal:  J Thromb Haemost       Date:  2015-05-02       Impact factor: 5.824

View more
  1 in total

Review 1.  Control of Blood Coagulation by Hemocompatible Material Surfaces-A Review.

Authors:  Janna Kuchinka; Christian Willems; Dmitry V Telyshev; Thomas Groth
Journal:  Bioengineering (Basel)       Date:  2021-12-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.